|
"hsu kh"的相關文件
顯示項目 6-30 / 55 (共3頁)
1 2 3 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2023-02-28 |
Adjuvant chemotherapy compared with observation in patients with T2aN0 stage IB lung adenocarcinoma
|
Lee, PH;Chiang, CJ;Tseng, JS;Zheng, ZR;Chen, KC;Chu, CH;Huang, YH;Hsu, KH;Lee, WC;Yang, TY;Liu, TW;Hsia, JY;Chang, GC |
| 國家衛生研究院 |
2022-03-01 |
Association of smoking with patient characteristics and outcomes in small cell lung carcinoma, 2011-2018
|
Tseng, JS;Chiang, CJ;Chen, KC;Zheng, ZR;Yang, TY;Lee, WC;Hsu, KH;Huang, YH;Liu, TW;Hsia, JY;Chang, GC |
| 國家衛生研究院 |
2021-04-30 |
Higher CD4/CD8 ratio of pleural effusion predicts better survival for lung cancer patients receiving immune checkpoint inhibitors
|
Lee, PH;Yang, TY;Chen, KC;Huang, YH;Tseng, JS;Hsu, KH;Wu, YC;Liu, KJ;Chang, GC |
| 國家衛生研究院 |
2021-03 |
Association between arsenic exposure, DNA damage, and urological cancers incidence: A long-term follow-up study of residents in an arseniasis endemic area of northeastern Taiwan
|
Tsai, TL;Kuo, CC;Hsu, LI;Tsai, SF;Chiou, HY;Chen, CJ;Hsu, KH;Wang, SL |
| 中山醫學大學 |
2021 |
The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study
|
Huang, YH; Hung, JY; Ko, HW; Su, PL; Lai, CL; Chang, HC; Hsia, TC; Lin, SH; Wu, KL; Yang, CT; Su, WC; Chu, YC; Wang, CC; Liao, WY; Lin, YT; Lin, CH; Lin, MC; Hsu, KH; Tseng, JS; Yang, TY; Chen, KC; Lee, MH; Yu, SL; Ho, CC; Chang, GC |
| 中山醫學大學 |
2021 |
Primary Tumor Radiotherapy During EGFR-TKI Disease Control Improves Survival of Treatment Naive Advanced EGFR-Mutant Lung Adenocarcinoma Patients
|
Hsu, KH; Huang, JW; Tseng, JS; Chen, KW; Weng, YC; Yu, SL; Yang, TY; Huang, YH; Chen, JJ; Chen, KC; Chang, GC |
| 中山醫學大學 |
2021 |
Primary Tumor Resection Is Associated with a Better Outcome among Advanced EGFR-Mutant Lung Adenocarcinoma Patients Receiving EGFR-TKI Treatment
|
Tseng, JS; Hsu, KH; Zheng, ZR; Yang, TY; Chen, KC; Huang, YH; Su, KY; Yu, SL; Chang, GC |
| 中山醫學大學 |
2021 |
Impact of tumor disappearance ratio on the prognosis of lung adenocarcinoma <= 2 cm in size: A retrospective cohort study
|
Wu, JJ; Wu, CY; Wu, CY; Wang, CL; Yang, TY; Tseng, JS; Hsu, KH; Huang, YH; Hsu, CP; Chuang, CY; Lin, CH; Tseng, CH; Chen, KC; Chang, GC |
| 中山醫學大學 |
2021 |
Genome-Wide Epigenetic Landscape of Lung Adenocarcinoma Links HOXB9 DNA Methylation to Intrinsic EGFR-TKI Resistance and Heterogeneous Response
|
Su, SF; Liu, CH; Cheng, CL; Ho, CC; Yang, TY; Chen, KC; Hsu, KH; Tseng, JS; Chen, HW; Chang, GC; Yu, SL; Li, KC |
| 中山醫學大學 |
2021 |
The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M
|
Huang, YH; Tseng, JS; Hsu, KH; Chen, KC; Su, KY; Yu, SL; Chen, JJW; Yang, TY; Chang, GC |
| 中山醫學大學 |
2021 |
Real-world efficacy and safety of lorlatinib in treating advanced ALK-positive non-small cell lung cancer patients
|
Lee, PH; Chen, KC; Hsu, KH; Huang, YH; Tseng, JS; Yang, TY; Chang, GC |
| 中山醫學大學 |
2021 |
Higher CD4/CD8 ratio of pleural effusion predicts better survival for lung cancer patients receiving immune checkpoint inhibitors
|
Lee, PH; Yang, TY; Chen, KC; Huang, YH; Jeng-Sen Tseng; Hsu, KH; Wu, YC; Liu, KJ; Chang, GC |
| 中山醫學大學 |
2020 |
ALK variants, PD-L1 expression, and their association with outcomes in ALK-positive NSCLC patients
|
Chang, GC; Yang, TY; Chen, KC; Hsu, KH; Huang, YH; Su, KY; Yu, SL; Tseng, JS |
| 中山醫學大學 |
2020 |
Landscape of Mitochondria Genome and Clinical Outcomes in Stage 1 Lung Adenocarcinoma
|
Raghav, L; Chang, YH; Hsu, YC; Li, YC; Chen, CY; Yang, TY; Chen, KC; Hsu, KH; Tseng, JS; Chuang, CY; Lee, MH; Wang, CL; Chen, HW; Yu, SL; Su, SF; Yuan, SS; Chen, JJW; Ho, SY; Li, KC; Yang, PC; Chang, GC; Chen, HY |
| 國家衛生研究院 |
2019-01-18 |
The relationship between air pollution and lung cancer in non-smokers in Taiwan
|
Tseng, CH;Tsuang, BJ;Chiang, CJ;Ku, KC;Tseng, JS;Yang, TY;Hsu, KH;Chen, KC;Yu, SL;Lee, WC;Liu, TW;Chan, CC;Chang, GC |
| 國家衛生研究院 |
2018-09-12 |
Norepinephrine administration is associated with higher mortality in dialysis requiring acute kidney injury patients with septic shock
|
Chen, YY;Wu, VC;Huang, WC;Yeh, YC;Wu, MS;Huang, CC;Wu, KD;Fang, JT;Wu, CJ;Wu, VC;Lai, TS;Lin, YF;Tsai, IJ;Lai, CF;Huang, TM;Chu, TS;Chen, YM;Chang, YH;Yeh, YC;Lai, CH;Tseng, LJ;Wu, KD;Wang, JJ;Chen, CY;Shiao, CC;Wang, WJ;Lin, JH;Wu, CH;Wu, CJ;Lu, KC;Kan, WC;Huang, CC;Chou, CY;Yang, YF;Tsai, JP;Hu, FC;Lee, CT;Chen, JB;Lee, CH;Lee, WC;Li, LC;Chen, TC;Lin, HYH;Chen, YC;Lee, CC;Sun, CY;Pan, HC;Chang, MY;Jenq, CC;Lin, CY;Chang, CH;Tsai, TY;Chen, CM;Lin, ET;Wu, CJ;Lin, CJ;Wu, PC;Kuo, FC;Weng, CJ;Chen, LK;Lin, SL;Yang, WS;Hsu, WD;Leu, JG;Chang, JT;Liou, HH;Hsu, KH;Wu, MJ;Huang, CT;You, ZH;Chang, CF;Chen, TW;Chen, HH;Chang, FC;Lin, YC;Wu, MS;Kao, CC;Hung, SC;Kuo, KL;Wu, CH;Tarng, DC;Chen, JY;Yang, CY;Lee, KH;Ko, SW;The NSARF and CAKS Group |
| 國家衛生研究院 |
2018-07 |
Arsenic, DNA damage, and cancers of bladder and kidney - a long-term follow-up of residents in arseniasis endemic area of north-eastern Taiwan
|
Wang, SL;Tsai, SF;Hsu, LI;Chen, CJ;Hsu, KH;Chiou, HY |
| 國家衛生研究院 |
2017-10-12 |
EGFR mutation, smoking, and gender in advanced lung adenocarcinoma
|
Tseng, CH;Chiang, CJ;Tseng, JS;Yang, TY;Hsu, KH;Chen, KC;Wang, CL;Chen, CY;Yen, SH;Tsai, CM;Huang, MS;Ho, CC;Yu, CJ;Tsai, YH;Chen, JS;Chou, TY;Tsai, MH;Chen, HY;Su, KY;Chen, JJW;Chen, HW;Yu, SL;Liu, TW;Chang, GC |
| 國家衛生研究院 |
2016-07 |
KIT exon 11 codons 557-558 deletion mutation promotes liver metastasis through the CXCL12/CXCR4 axis in gastrointestinal stromal tumors
|
Wang, HC;Li, TY;Chao, YJ;Hou, YC;Hsueh, YS;Hsu, KH;Shan, YS |
| 國家衛生研究院 |
2016-07 |
Characteristics of young lung cancer: Analysis of Taiwan's nationwide lung cancer registry focusing on epidermal growth factor receptor mutation and smoking status
|
Hsu, CH;Tseng, CH;Chiang, CJ;Hsu, KH;Tseng, JS;Chen, KC;Wang, CL;Chen, CY;Yen, S;Chiu, CH;Huang, MS;Yu, CJ;Tsai, YH;Chen, JS;Tsai, CM;Chou, TY;Lin, KC;Tsai, MH;Lee, WC;Ku, HY;Liu, TW;Yang, TY;Chang, GC |
| 國家衛生研究院 |
2015-07 |
R331W missense mutation of oncogene YAP1 is a germline risk allele for lung adenocarcinoma with medical actionability
|
Chen, HY;Yu, SL;Ho, BC;Su, KY;Hsu, YC;Chang, CS;Li, YC;Yang, SY;Hsu, PY;Ho, H;Chang, YH;Chen, CY;Yang, HI;Hsu, CP;Yang, TY;Chen, KC;Hsu, KH;Tseng, JS;Hsia, JY;Chuang, CY;Yuan, S;Lee, MH;Liu, CH;Wu, GI;Hsiung, CA;Chen, YM;Wang, CL;Huang, MS;Yu, CJ;Chen, KY;Tsai, YH;Su, WC;Chen, HW;Chen, JJ;Chen, CJ;Chang, GC;Yang, PC;Li, KC |
| 國立交通大學 |
2014-12-08T15:40:08Z |
Evaporation model of a single hydrocarbon fuel droplet due to ambient turbulence at intermediate Reynolds numbers
|
Wu, JS; Hsu, KH; Kuo, PM; Sheen, HJ |
| 國立交通大學 |
2014-12-08T15:16:23Z |
Development of a parallel Poisson's equation solver with adaptive mesh refinement and its application in field emission prediction
|
Hsu, KH; Chen, PY; Hung, CT; Chen, LH; Wu, JS |
| 臺北醫學大學 |
2014 |
Oral adsorbent AST-120 potentiates the effect of erythropoietin-stimulating agents on Stage 5 Chronic kidney disease patients: a randomized crossover study
|
Wu, IW;Hsu, KH;Sun, CY;Tsai, CJ;Wu, MS;Lee, CC |
| 臺北醫學大學 |
2014 |
Multidisciplinary predialysis education reduced the inpatient and total medical costs of the first 6 months of dialysis in incident hemodialysis patients
|
YJ1, Yu;Wu, IW;Huang, CY;Hsu, KH;Lee, CC;Sun, CY;Hsu, HJ;Wu, MS |
顯示項目 6-30 / 55 (共3頁)
1 2 3 > >>
每頁顯示[10|25|50]項目
|
